The Oncology Institute, Inc.
TOI
$2.78
-$0.015-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.79% | 22.16% | 6.75% | -18.10% | -48.50% |
| Total Depreciation and Amortization | 8.03% | 7.05% | 12.19% | 27.58% | 29.83% |
| Total Amortization of Deferred Charges | 54.14% | 1.61% | 1.58% | 13.63% | 57.32% |
| Total Other Non-Cash Items | -55.87% | -76.87% | -57.01% | 116.13% | 901.44% |
| Change in Net Operating Assets | 443.14% | 665.54% | 226.50% | 94.92% | 125.42% |
| Cash from Operations | 57.43% | 26.92% | 25.42% | 25.23% | 38.99% |
| Capital Expenditure | -5.06% | 17.04% | 49.22% | 29.09% | 47.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 96.73% | 96.06% | 48.05% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.99% | -30.23% | 116.66% | 191.29% | 173.43% |
| Cash from Investing | -58.16% | -26.23% | 223.14% | 173.85% | 156.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -562.77% | 64.54% | 35.38% | 66.78% | 39.81% |
| Issuance of Common Stock | 7,687.94% | -40.48% | -58.68% | -61.42% | -76.81% |
| Repurchase of Common Stock | -- | -- | 100.00% | 86.02% | 89.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.06% | 8.20% | -764.78% | 4.96% | 47.87% |
| Cash from Financing | -20.05% | 49.00% | 13.60% | -105.61% | -106.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.29% | -16.93% | 158.62% | 121.33% | 125.91% |